PFM Health Sciences Revenue and Competitors
Estimated Revenue & Valuation
- PFM Health Sciences's estimated annual revenue is currently $2.6M per year.
- PFM Health Sciences's estimated revenue per employee is $129,390
Employee Data
- PFM Health Sciences has 20 Employees.
- PFM Health Sciences grew their employee count by 11% last year.
PFM Health Sciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Compliance Officer | Reveal Email/Phone |
2 | Partner | Reveal Email/Phone |
PFM Health Sciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 0 | N/A | N/A | N/A |
#2 | $329.2M | 1014 | 21% | $8.7M | N/A |
#3 | $25.4M | 112 | 14% | N/A | N/A |
#4 | $6M | 34 | 10% | N/A | N/A |
#5 | $14.3M | 77 | 17% | N/A | N/A |
#6 | $8.2M | 42 | 0% | N/A | N/A |
#7 | $143.3M | 477 | 2% | N/A | N/A |
#8 | $582.2M | 1832 | -88% | N/A | N/A |
#9 | $74.9M | 288 | 4% | N/A | N/A |
#10 | $30.2M | 115 | -4% | N/A | N/A |
What Is PFM Health Sciences?
N/A
Total Funding
20
Number of Employees
$2.6M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PFM Health Sciences News
2022-04-13 - institutional investors of Caribou Biosciences, Inc. (NASDAQ:CRBU) must be
disappointed after last week's 9.4% drop
PFM Health Sciences, LP is currently the largest shareholder, with 6.7% of shares outstanding. The second and third largest shareholders are...
2022-03-22 - Artificial Disc Market to Expand at a Considerable CAGR of ...
KG, Aditus Medical, Evospine GmbH, Prodorth Spine, SIGNUS Medizintechnik ... Aesculap, Inc, B. Braun Company, Exsurco Medical, PFM Medical,...
2022-03-22 - Medtech's top 10 money raisers of 2021
Caris Life Sciences is no stranger to VC megarounds, ... Watrium, Cambridge Innovation Capital, PFM Health Sciences, GE Healthcare.
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.7M | 20 | -5% | N/A |
#2 | $4.1M | 20 | -13% | N/A |
#3 | $3.6M | 20 | -33% | N/A |
#4 | $2M | 20 | N/A | N/A |
#5 | $2M | 20 | N/A | N/A |